key: cord-0747945-5nw3828d
authors: de Souza, Tiago H.; Nadal, José A.; Nogueira, Roberto J. N.; Pereira, Ricardo M.; Brandão, Marcelo B.
title: Clinical manifestations of children with COVID‐19: A systematic review
date: 2020-06-15
journal: Pediatr Pulmonol
DOI: 10.1002/ppul.24885
sha: 76c79adc0b54fa63eb015e402aec820f5edd34a9
doc_id: 747945
cord_uid: 5nw3828d

BACKGROUND: The coronavirus disease 2019 (COVID‐19) outbreak is an unprecedented global public health challenge, leading to thousands of deaths every day worldwide. Despite the epidemiological importance, clinical patterns of children with COVID‐19 remain unclear. The aim of this study was to describe the clinical, laboratorial, and radiological characteristics of children with COVID‐19. METHODS: The Medline database was searched between December 1st 2019 and April 6th 2020. No language restrictions were applied. Inclusion criteria were (a) studied patients younger than 18 years old; (b) presented original data from cases of COVID‐19 confirmed by reverse‐transcription polymerase chain reaction; and (c) contained descriptions of clinical manifestations, laboratory tests, or radiological examinations. RESULTS: A total of 38 studies (1124 cases) were included. From all the cases, 1117 had their severity classified: 14.2% were asymptomatic, 36.3% were mild, 46.0% were moderate, 2.1% were severe, and 1.2% were critical. The most prevalent symptom was fever (47.5%), followed by cough (41.5%), nasal symptoms (11.2%), diarrhea (8.1%), and nausea/vomiting (7.1%). One hundred forty‐five (36.9%) children were diagnosed with pneumonia and 43 (10.9%) upper airway infections were reported. Reduced lymphocyte count was reported in 12.9% of cases. Abnormalities in computed tomography were reported in 63.0% of cases. The most prevalent abnormalities reported were ground‐glass opacities, patchy shadows, and consolidations. Only one death was reported. CONCLUSIONS: Clinical manifestations of children with COVID‐19 differ widely from adult cases. Fever and respiratory symptoms should not be considered a hallmark of COVID‐19 in children.

In late December 2019, Chinese authorities informed the World Health Organization (WHO) that, due to unknown cause, an outbreak of pneumonia emerged in Wuhan, Hubei province. On 7 January 2020, a new type of coronavirus (severe acute respiratory syndrome coronavirus 2 [SARS-CoV-2]) was isolated, and later named "coronavirus disease 2019" (abbreviated "COVID-19"). The first death caused by COVID-19 was on 9 January 2020, in Wuhan and since then more than 370 000 cases and 16 000 deaths occurred worldwide. 1 Currently, the death toll in Italy has far surpassed the number registered in China, and the United States became the new COVID-19 epicenter.

In spite of stepped-up efforts to contain the pandemic, the number of affected patients and the death toll continue to rise. Elderly patients infected with SARS-CoV-2 are at high risk to have severe acute respiratory syndrome, complications, and death. 2 Due to unknown reasons, children with COVID-19 appear to have a milder clinical course compared to adults, and reports of death are scarce. 3, 4 However, the pediatric population may play a major role in the community spread of SARS-CoV-2. In addition to viral shedding in nasal secretions, there is evidence of fecal shedding for several weeks after diagnosis, which poses a challenge for infection control. 5 Despite the epidemiological importance, clinical patterns of children with COVID-19 remain unclear. The WHO recommends testing all suspected cases, however, children infected with SARS-CoV-2 may not meet all the criteria required in the suspected case definition. 6 The objective of this study is to describe the clinical, laboratorial, and radiological characteristics of children with COVID-19 reported in the literature.

This review was performed in accordance with the Preferred Reporting Items for Systematic and Meta-Analysis statement. 7, 8 The Medline database was searched using the following search strategy:

((((COVID-19) OR coronavirus) OR SARS-CoV-2)) AND (((((((pediatrics) OR children) OR neonates) OR child) OR neonate) OR infant) OR infants). No language restrictions were applied. Articles published between December 1st 2019 and April 7th 2020 were evaluated for inclusion. No attempts were made to contact the study authors for identifying missing and confusing data. A manual search of the references found in the selected articles and reviews was also performed.

Two authors (THS and JAN) screened the titles and abstracts independently and in duplicate for potential eligibility. They subsequently read the full texts to determine final eligibility. Discrepancies were resolved through discussion and consensus, and if necessary, the assistance of a third author (MBB) was sought.

Eligible studies fulfilled the following criteria: (a) studied patients younger than 18 years old; (b) presented original data from cases of COVID-19 confirmed by reverse-transcription polymerase chain reaction; (c) contained descriptions of clinical manifestations, laboratory tests, or radiological examinations.

A structured data extraction form was piloted and then used to extract data from the reports of all included studies in duplicate and independently by two authors (THS and JAN). Discrepancies in extracted data were resolved through discussion. The following data were extracted, when available, from each selected article: first author, publication year, study design, number of cases, gender, age, clinical manifestations, laboratory tests, radiological examinations, and outcomes (discharged, still hospitalized, or death).

When sufficient data were reported, the cases were classified into the following clinical types 9 :

1. Asymptomatic infection: without any clinical symptoms and signs and the chest imaging is normal, while the SARS-CoV-2 nucleic acid test was positive or the serum-specific antibody was retrospectively diagnosed as infection. shows lung lesions, which are subclinical. 5. Severe: early respiratory symptoms such as fever and cough, may be accompanied by gastrointestinal symptoms such as diarrhea.

The disease usually progresses around 1 week, and dyspnea occurs, with central cyanosis. Oxygen saturation is less than 92%, with other hypoxia manifestations.

6. Critical: children can quickly progress to acute respiratory distress syndrome or respiratory failure, and may also have shock, encephalopathy, myocardial injury or heart failure, coagulation dysfunction, and acute kidney injury, including multiple organ dysfunction. 38 one in Iran, 45 one in Singapore, 28 one in Korea, 23 and one in Vietnam. 31 

A total of 1117 cases had their severity classified based on the reported clinical data. One hundred fifty-nine (14.2%) cases were asymptomatic, 406 (36.3%) were mild, 514 (46.0%) were moderate, 25 (2.1%) were severe, and 13 (1.2%) were critical cases. The severity of illness of the reported cases is illustrated in Figure 2 . Details on the ventilatory support used were described in 10 critical cases (nine children and one newborn). 3, 12, 16, 27, 43 Eight children underwent invasive mechanical ventilation and one premature newborn who suffered fetal distress received noninvasive ventilation. 

The most prevalent symptom was fever, reported in 47.5% of the cases, followed by cough (41.5%), nasal symptoms (11.2%), diarrhea (8.1%), nausea/vomiting (7.1%), fatigue (5.0%), and respiratory distress (3.5%).

The nasal symptoms described were runny nose and nasal congestion, symptoms of loss of smell were not described. One hundred forty-five Table 2 . All clinical manifestations described in each study are presented in E- Table 1 in the Supporting Information. 

Clinical outcomes of death, discharged or still hospitalized were described for 371 cases in 32 studies. 3, 5, [11] [12] [13] [14] [16] [17] [18] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] 31, [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] 44, 45 Of these, 62 cases were still hospitalized when studies were submitted, 308 were discharged and one died. 

In our study, we described the main clinical, laboratorial, and radiological characteristics of children infected with SARS-CoV-2 reported in the literature. It was observed that only a small proportion of infected children became severely or critically ill. About half of the children with COVID-19 were asymptomatic or mild cases, and several were classified as moderate due to radiological abnormalities in spite of their mild clinical manifestations. The prognosis seems to be very good, with recovery described in the vast majority of reported cases. Only one death was reported in the included studies, a 10-month-old child with intussusception. 3 Since COVID-19 has a favorable clinical course in children, the importance of pediatric cases is mainly due to epidemiological issues. 46 Despite being mild or asymptomatic cases, prolonged viral shedding in stool and nasal secretions made children possible facilitators of viral transmission. 5, 47 In the study of Xu et al, 47 there was no report of children with a multisystem inflammatory condition related to SARS-CoV-2 infection.

The vast majority of children with COVID-19 have a favorable clinical course and their clinical manifestations differ widely from adult cases.

Fever and respiratory symptoms should not be considered a hallmark of COVID-19 in children. Therefore, pediatricians should have a high level of clinical suspicion to diagnose children infected with SARS-Cov-2, as the majority of pediatric cases are asymptomatic or mild. Regardless of the favorable prognosis, it is important that the child's role in the contamination chain is precisely established and considered.

The authors thank Carolina Grotta Ramos Telio for her review of the manuscript.

The authors declare that there are no conflict of interests.

Tiago Henrique de Souza conceptualized and designed the study, drafted the initial manuscript, and reviewed and revised the manuscript. Tiago Henrique de Souza and José Antonio Hersan Nadal designed the data collection instruments, collected data, carried out the initial analyses, and reviewed and revised the manuscript.

Roberto José Negrão Nogueira, Ricardo Mendes Pereira, and Marcelo Barciela Brandão coordinated and supervised data collection, and critically reviewed the manuscript for important intellectual content. All authors approved the final manuscript as submitted and agree to be accountable for all aspects of the work.

Tiago H. de Souza http://orcid.org/0000-0001-6944-0221

Characteristics and outcomes of 21 critically Ill patients with COVID-19 in washington state

SARS-CoV-2 infection in children

Clinical characteristics of coronavirus disease 2019 in china

A case series of children with 2019 novel coronavirus infection: clinical and epidemiological features

Clinical outcome of 55 asymptomatic cases at the time of hospital admission infected with SARS-Coronavirus-2 in Shenzhen

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

The Society of Pediatrics CMA, the Editorial Board CJ of P. Recommendations for the diagnosis, prevention and control of the 2019 novel coronavirus infection in children (first interim edition)

COVID-19 in children: initial characterization of the pediatric disease

Clinical analysis of 31 cases of 2019 novel coronavirus infection in children from six provinces (autonomous region) of northern China

Clinical characteristics of children with coronavirus disease 2019 in Hubei, China

Clinical and CT features in pediatric patients with COVID-19 infection: different points from adults

Analysis of CT features of 15 children with 2019 novel coronavirus infection

Novel coronavirus infection in hospitalized infants under 1 year of age in China

Clinical features of severe pediatric patients with coronavirus disease 2019 in Wuhan: a single center's observational study

Detection of Covid-19 in children in early january 2020 in Wuhan, China

Clinical characteristics of 24 asymptomatic infections with COVID-19 screened among close contacts in Nanjing

Clinical and CT imaging features of the COVID-19 pneumonia: focus on pregnant women and children

Three children who recovered from novel coronavirus 2019 pneumonia

Insight into COVID-2019 for pediatricians

Clinical features of pediatric patients with COVID-19: a report of two family cluster cases

First pediatric case of coronavirus disease 2019 in Korea

A 55-day-old female infant infected with COVID 19: presenting with pneumonia, liver injury, and heart damage

Detection of novel coronavirus by RT-PCR in stool specimen from asymptomatic child

2019-novel coronavirus infection in a three-month-old baby

First case of severe childhood novel coronavirus pneumonia in China

A well infant with coronavirus disease 2019 (COVID-19) with high viral load

A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-toperson transmission: a study of a family cluster

High-resolution computed tomography manifestations of 5 pediatric patients with 2019 novel coronavirus

The first infant case of COVID-19 acquired from a secondary transmission in Vietnam

Asymptomatic cases in a family cluster with SARS-CoV-2 infection

The different clinical characteristics of corona virus disease cases between children and their families in China-the character of children with COVID-19

Clinical features and chest CT findings of coronavirus disease 2019 in infants and young children

Twin girls infected with SARS-CoV-2

Clinical and epidemiological features of 36 children with coronavirus disease 2019 (COVID-19) in Zhejiang, China: an observational cohort study

First case of 2019 novel coronavirus infection in children in Shanghai

COVID-19 infection in a paucisymptomatic infant: raising the index of suspicion in epidemic settings

Detectable SARS-CoV-2 viral RNA in feces of three children during recovery period of COVID-19 pneumonia

The isolation period should be longer: lesson from a child infected with SARS-CoV-2 in Chongqing, China

First case of neonate infected with novel coronavirus pneumonia in China. Zhonghua Er Ke Za Zhi

SARS-CoV-2 infection with gastrointestinal symptoms as the first manifestation in a neonate

Neonatal early-onset infection with SARS-CoV-2 in 33 neonates born to mothers with COVID-19 in Wuhan, China. JAMA Pediatr

Clinical features and obstetric and neonatal outcomes of pregnant patients with COVID-19 in Wuhan, China: a retrospective, single-centre, descriptive study

Novel coronavirus in a 15-day-old neonate with clinical signs of sepsis, a case report

Characteristics and outcomes of children with coronavirus disease 2019 (COVID-19) infection admitted to US and canadian pediatric intensive care units

Characteristics of pediatric SARS-CoV-2 infection and potential evidence for persistent fecal viral shedding

Updated guidance on evaluating and testing persons for coronavirus disease

World Health Organization. Global Surveillance for human infection with coronavirus disease (COVID-19)

Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study

Rates of co-infection between SARS-CoV-2 and other respiratory pathogens

Clinical manifestations of children with COVID-19: A systematic review